WHO names seven candidates as the director-general race moves into public view
Seven candidates have been proposed by WHO Member States for the organization’s next Director-General, setting up a formal succession process that will stretch from late 2026 into mid-2027. The field includes Dr Hanan Mohammed Al-Kuwari, Dr Hanan Balkhy, Dr Hans Henri P. Kluge, Dr María P. Neira, Mr Budi Gunadi Sadikin, Dr Li Song, and Dr Gevorg Tamamyan. Their curricula vitae are available in all official WHO languages, a procedural detail that reflects the organization’s effort to keep the election process visible across its global membership rather than confined to a small diplomatic circle.
The announcement arrives at a moment when WHO leadership carries outsized weight for outbreak response, health-system coordination, and the politics of multilateral health governance. The director-general does far more than manage an agency; the office sets the tone for how WHO responds to health emergencies, engages governments, and frames global priorities for the years ahead. In practical terms, the election will shape how the organization balances technical authority with the demands of Member States that often approach global health through very different political and economic lenses.
The first public test for the candidates comes on 18–19 November 2026, when they will engage with Member States and Associate Members at a forum at WHO headquarters in Geneva. The forum will be webcast publicly in Arabic, Chinese, English, French, Russian, and Spanish. In a process that has historically been driven by diplomacy and internal deliberation, the decision to place candidates in a public setting creates a more transparent window into their priorities, communication style, and command of WHO’s core mission. For Member States, it also offers a chance to compare not just credentials but institutional judgment: who can steer a sprawling global health agency through outbreaks, financing pressures, and persistent inequities in access to care?
The timeline is deliberate. At its 160th session in early 2027, the Executive Board will choose a shortlist of five candidates. Board members will then interview those finalists and nominate up to three for consideration by the World Health Assembly. A second candidates’ forum will follow on 15 March 2027, again open to public webcast in all official languages. The process ends at the World Health Assembly’s 80th session in May 2027, where the next director-general will be appointed and scheduled to take office on 16 August 2027.
One sentence captures the stakes plainly: WHO is choosing its next chief executive while the global health system remains under pressure.
How WHO’s governing bodies will decide the final outcome
The election procedure depends on two bodies that sit at the center of WHO governance. The World Health Assembly is the organization’s decision-making body, attended by delegations from all Member States. Its responsibilities include setting policy, appointing the director-general, supervising financial policy, and reviewing and approving the proposed programme budget. The Executive Board, composed of 34 technically qualified members elected for three-year terms, does much of the preparatory work. It meets twice a year, including in January to agree on the agenda and resolutions to be considered by the World Health Assembly, and again in May after the Assembly.
That sequence gives the election both structure and constraint. The broader membership will see the candidates in public forums, but the field will be narrowed in stages by the Executive Board before the final appointment is made by the Assembly. Each step matters because it filters not only leadership style but also geopolitical acceptability. WHO has to operate across regions, ministries, donors, and emergency settings; the next director-general will need to hold credibility with governments that may disagree sharply on surveillance, preparedness, pandemic financing, or access to medicines.
The availability of candidate curricula vitae in Arabic, Chinese, English, French, Russian, and Spanish also signals something more than a courtesy translation. WHO is trying to ensure that its member governments can assess each nominee in the languages that shape their own policy and diplomatic work. That matters in an election where perception of competence may be shaped as much by communication and governance experience as by formal public health training.
The forum schedule also invites broader scrutiny of leadership philosophy. A director-general of WHO must handle disease outbreaks, long-term system strengthening, and the organization’s role as a convening authority. In global health, legitimacy often depends on whether the office can speak clearly during crisis and remain steady during negotiation. The coming forums will force each candidate to show how they would manage both roles at once.
WHO’s announcement does not name a favorite, and it does not need to. By laying out the full sequence now, the organization has fixed the timetable for a leadership transition that will culminate in May 2027 and a new term beginning on 16 August 2027. The public forums, the Executive Board shortlist, and the World Health Assembly vote will together determine which candidate inherits an institution under constant scrutiny and permanent demand.
The unanswered question is not procedural; it is institutional. The process will reveal which candidate can command consensus across a fragmented global membership while preserving WHO’s technical authority when the next health emergency arrives.